90326590 - IMMUNOCHARGING

Information

• Trademark
• 90326590

• Source

• Serial Number

  90326590

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 18, 2020
  4 years ago

• Transaction Date

  September 05, 2023
  a year ago

• Status Date

  September 04, 2023
  a year ago

• Published for Opposition Date

  June 08, 2021
  3 years ago

• Location Date

  August 03, 2021
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  SCHMIDT, JOHN JOSEPH

• Attorney Docket Number

  CLTY2121US

  Attorney Name

  Camille M. Miller

  Law Office Assigned Location Code

  N10

• Owners

  • Celularity, Inc.

Case File Statements

• GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; surgical implants comprised of living tissue, namely, human amniotic membrane and human chorionic membrane intended for subsequent implantation; surgical implants comprised of living tissue, namely, human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use in the nature of biological preparations, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treating cancer or other disease-associated antigen; pharmaceutical preparations for wounds, namely, biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; written instructional materials distributed in connection with the aforesaid goods packaged with the goods; biological products for medical use, namely, biological preparations in the nature of placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treatment of cancer or other disease-associated antigen
• PM0001: IMMUNO CHARGING
• GS0011: Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
• GS0421: Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Case File Event Statements

• 9/5/2023 - a year ago

  26 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 9/4/2023 - a year ago

  25 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 12/29/2022 - 2 years ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/27/2022 - 2 years ago

  23 - SOU EXTENSION 3 GRANTED Type: EX3G

• 12/27/2022 - 2 years ago

  22 - SOU EXTENSION 3 FILED Type: EXT3

• 12/27/2022 - 2 years ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/7/2022 - 2 years ago

  20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/5/2022 - 2 years ago

  19 - SOU EXTENSION 2 GRANTED Type: EX2G

• 7/5/2022 - 2 years ago

  18 - SOU EXTENSION 2 FILED Type: EXT2

• 7/5/2022 - 2 years ago

  17 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/5/2022 - 3 years ago

  16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/3/2022 - 3 years ago

  15 - SOU EXTENSION 1 GRANTED Type: EX1G

• 1/3/2022 - 3 years ago

  14 - SOU EXTENSION 1 FILED Type: EXT1

• 1/3/2022 - 3 years ago

  13 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/3/2021 - 3 years ago

  12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/8/2021 - 3 years ago

  11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/8/2021 - 3 years ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/19/2021 - 3 years ago

  9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/3/2021 - 3 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/3/2021 - 3 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/3/2021 - 3 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/3/2021 - 3 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/3/2021 - 3 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/30/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/21/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/21/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP